vs
Side-by-side financial comparison of Bragg Gaming Group Inc. (BRAG) and InflaRx N.V. (IFRX). Click either name above to swap in a different company.
InflaRx N.V. is the larger business by last-quarter revenue ($25.7K vs $20.8K, roughly 1.2× Bragg Gaming Group Inc.).
Bragg Gaming Group Inc. is a global B2B provider of turnkey gaming technology solutions, content aggregation services, and player engagement tools for licensed online casino and sports betting operators. It primarily serves regulated online gambling markets across North America, Europe, and Latin America, offering fully customizable, compliance-aligned platform products for its client base.
InflaRx N.V. is a clinical-stage biopharmaceutical company specializing in the development of novel anti-inflammatory therapies targeting the complement C5a pathway. Its pipeline addresses unmet medical needs for severe inflammatory diseases including autoimmune and rare inflammatory disorders, serving global patient populations.
BRAG vs IFRX — Head-to-Head
Income Statement — Q2 FY2022 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.8K | $25.7K |
| Net Profit | $90 | — |
| Gross Margin | 55.9% | 98.6% |
| Operating Margin | 3.6% | — |
| Net Margin | 0.4% | — |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.00 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $25.7K | ||
| Q2 25 | — | $42.6K | ||
| Q2 24 | — | $6.9K | ||
| Q2 22 | $20.8K | — | ||
| Q1 22 | $19.4K | — |
| Q3 25 | — | — | ||
| Q2 25 | — | $-15.6M | ||
| Q2 24 | — | $-15.0M | ||
| Q2 22 | $90 | — | ||
| Q1 22 | $-720 | — |
| Q3 25 | — | 98.6% | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 22 | 55.9% | — | ||
| Q1 22 | 51.8% | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 22 | 3.6% | — | ||
| Q1 22 | -1.2% | — |
| Q3 25 | — | — | ||
| Q2 25 | — | -36559.8% | ||
| Q2 24 | — | -217803.1% | ||
| Q2 22 | 0.4% | — | ||
| Q1 22 | -3.7% | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 22 | $0.00 | — | ||
| Q1 22 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $7.5K | $-33.1M |
| Free Cash FlowOCF − Capex | $7.3K | — |
| FCF MarginFCF / Revenue | 35.2% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | 82.92× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-33.1M | ||
| Q2 25 | — | — | ||
| Q2 24 | — | $-29.2M | ||
| Q2 22 | $7.5K | — | ||
| Q1 22 | $3.8K | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 22 | $7.3K | — | ||
| Q1 22 | $3.7K | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 22 | 35.2% | — | ||
| Q1 22 | 19.2% | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 22 | 0.7% | — | ||
| Q1 22 | 0.4% | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 22 | 82.92× | — | ||
| Q1 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BRAG
| Other | $11.1K | 54% |
| Netherlands | $9.6K | 46% |
IFRX
Segment breakdown not available.
